Rida Noor

University of Colorado Boulder

Papers

1

Total Citations

7

H-Index

1

About

Dr. Rida Noor is a pioneering cancer researcher whose work centers on the molecular mechanisms of DNA repair and the development of novel therapeutic strategies. Her major contribution lies in the discovery and characterization of the PARP1-HPF1 complex, a critical player in histone PARylation that drives resistance to PARP inhibitors (PARPi) in BRCA-deficient cancers. By identifying this complex, Dr. Noor has opened new avenues for overcoming drug resistance and expanding the clinical utility of PARPi beyond BRCA-mutated tumors. Her landmark 2023 study on high-throughput screening (HTS) of PARP1-HPF1 inhibitors has already garnered 7 citations, underscoring its immediate impact on the field. This work not only addresses a key limitation in current cancer therapy but also provides a foundation for developing next-generation combination treatments. Dr. Noor’s research bridges fundamental biology and translational medicine, offering hope for patients with hard-to-treat cancers. Her innovative approach and dedication to solving pressing clinical challenges mark her as a rising leader in oncology and DNA repair research.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
HTS discovery of PARP1-HPF1 complex inhibitors in cancer
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Colorado Boulder

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago